Latest in News & Research
FDA Approves Zoryve for Atopic Dermatitis
The once-daily, nonsteroidal cream is approved for adults and children 6 years and older
Distinct Recurrence Patterns Seen for Primary, Relapsed Cutaneous Melanoma
Significantly lower progression-free survival, reduced distant metastasis-free survival seen for BRAF-mutated CM with immune checkpoint inhibitor
Sustained Safety, Efficacy Seen for Dupilumab in Atopic Dermatitis
Sustained benefit seen for adults with moderate-to-severe AD during five-year open-label extension study
Adherence to Mediterranean Diet, Omega-3 Fatty Acids Beneficial in Acne
Reduction seen in inflammatory and noninflammatory lesions, improvement seen in overall quality of life with EPA/DHA
Comprehending Compensation: A Dermatologist’s Definitive Guide to Navigating Job Offers, Pay Structure, Benefits & More!
As a dermatologist, your journey through medical school and residency has equipped you with the expertise to diagnose and treat more than 3,000 skin,...
Rural Residents Continue to Have Higher Odds of Skin Cancer
Rural-urban differences magnified by lower income and race
Satisfaction With Hair Growth Seen With Ritlecitinib in Alopecia Areata
Proportion of patients allocated to ritlecitinib who were satisfied increased or was maintained at week 48
Rules-Based Triage System Improves Patient Stratification for Skin Cancer
Three high-risk lesion groups seen faster in the new triage pathway, with a mean reduction of 26 days
Psoriasis, With or Without Psoriatic Arthritis, Associated With Fatigue
Increasing joint pain intensity associated with overall fatigue in patients with psoriasis with or without psoriatic arthritis
Few Patients With Positive Margins After Basal Cell Excision Have Recurrence
Recurrence developed in more patients who did not receive additional treatment and in fewer receiving nonsurgical treatments
RVUs vs. Collections in Dermatology: Understanding Productivity and Revenue Metrics for Dermatologists
Understanding RVUs (Relative Value Units) and collections is crucial for dermatologists as these metrics play a significant role in how your compensation and productivity...
Study Identifies Prognostic Factors for Localized Adnexal Carcinomas
Radiotherapy only associated with longer progression-free survival in patients with unresectable locally advanced or metastatic tumors
Low Recurrence Seen for Excision of Melanoma in Situ With 5-mm Margin
99.1 percent of the 351 MISs identified from 292 patients did not have clinical recurrence after excision
Abrocitinib Effective, Tolerated for Prurigo Nodularis, Chronic Pruritus
Decrease in Peak Pruritus Numeric Rating Scale for PN, chronic pruritus of unknown origin patients
Nonsignificant Survival Benefit Seen for Dabrafenib, Trametinib in Melanoma
Consistent survival benefit seen across several prespecified subgroups, including those with a BRAFV600E mutation
Prior Radiotherapy Linked to Improved PFS for Cemiplimab-Treated cSCC
In univariate and multivariate analyses, significant correlations only seen between progression-free survival, previous radiotherapy
Meta-Analysis Identifies Factors Linked to Treatment Outcome in Psoriasis
Observational studies show negative links for older age, previous exposure to biologics, higher BMI, and smoking
Sign-On Bonuses in Dermatology: Your Questions Answered!
Lebrikizumab Tied to Sustained Atopic Dermatitis Treatment Effect
Findings seen despite negligible remaining lebrikizumab serum concentrations following treatment withdrawal
No Evidence That Live Vaccines Are Unsafe for Patients on Dupilumab
Systematic review shows vaccine efficacy not affected by dupilumab in general
Worst Itch Numeric Rating Scale Can Assess Itch in Prurigo Nodularis
Moderate-to-strong correlations support convergent validity; rating scale sensitive to change
Study Identifies Characteristics of Melanomas in Giant Pigmented Nevi
MGPN diagnoses occur at younger age than other melanomas; disease-specific, overall survival rates comparable to other melanomas
ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma
Neoadjuvant treatment followed by surgery results in longer event-free survival for resectable, macroscopic stage III melanoma
24 of 1239